04282017Headline:

Fresenius SE & Co. KGaA (Germany), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), and Halyard Health, Inc. (U.S.) Dominate the Global Enteral Feeding Devices Market

The global enteral feeding devices market is consolidated at the top with the top five market players accounting for more than 50% of the global market. Fresenius SE & Co. KGaA (Germany), Halyard Health, Inc. (U.S.), Abbott Laboratories (U.S.), and Medtronic plc (Ireland) lead the global enteral feeding devices market. Some of the other leading players in this market include B. Braun Melsungen AG (Germany), C. R. Bard, Inc. (U.S.), Cook Medical (U.S.), ConMed Corporation (U.S.), Moog, Inc. (U.S.), Nestlé S.A (Switzerland), and Boston Scientific Corporation (U.S.).

Fresenius SE & Co. KGaA (Germany) held the leading position in the global enteral feeding devices market in 2015. The company has a diversified product portfolio, which includes a wide range of enteral feeding devices, such as enteral feeding pumps, giving sets, nasoenteric feeding tubes, enterostomy tubes, and connectors. The company’s leading position in this market can be attributed to its strong distribution network across the globe, which enables it to serve customers in the Americas, Africa, Europe, and Asia-Pacific. Also, its strategic focus on introducing innovative products is indicative of its strong R&D investments. The growing focus of Fresenius on the acquisition of key players in the clinical nutrition industry has helped it to consolidate its share in the global enteral feeding devices market.

Medtronic plc has established a strong brand in the global enteral feeding devices industry. The company’s key growth strategies, such as the expansion of its existing production facilities and strengthening of R&D, have helped it to maintain its position in this competitive market. Geographically, the company has a strong presence in North America (about 66% revenue generated from this region in 2015), a major market for enteral feeding devices. The revenue generated from the company’s enteral feeding devices segment is expected to grow in the near future, owing to the successful implementation of organic and inorganic growth strategies. The company intends to strengthen its presence in emerging healthcare markets such as India, China, Brazil, and Turkey to garner a greater market share in the coming years. The closure of the enteral feeding division of Abbott Laboratories in North America, a leading market player in the enteral feeding devices market, has created a space in this market that Medtronic could occupy.

Abbott Laboratories has maintained its market position through its facilities in about 150 countries, across North America, South America, Africa, Europe, Middle East, Asia, and Oceania. The company offers enteral feeding pumps and giving sets. It has a major focus on product innovation, new product launches, and geographic expansion as its key business strategies to ensure its market growth. However, the company has discontinued the manufacture, lease, and sale of enteral feeding devices in the U.S., Canada, and Puerto Rico, which were the major markets for enteral feeding devices for the company. Currently, Abbott Laboratories is focusing on increasing its footprints across emerging countries in Asia-Pacific and Latin America.

The key strategies adopted by major players in the global enteral feeding devices market are new product launches, acquisitions, agreements, partnerships & collaborations, and geographic expansion. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions. Geographic expansion through establishment of new facilities or acquisitions is another major strategy adopted by global players in the enteral feeding devices market.

What Next?

Recent Articles